LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
---|---|---|---|---|---|---|---|---|---|---|
MCF 10A-H2B-mCherry | Dasatinib | 10 | 48.65 | 84.90 | 305 | 5328 | 0.0572 | 0.2388 | MN20160318_Q02 | N03 |
MCF 10A-H2B-mCherry | Dasatinib | 10 | 48.65 | 84.90 | 836 | 5328 | 0.1569 | 0.4667 | MN20160318_Q02 | N03 |
MCF 10A-H2B-mCherry | Dasatinib | 10 | 50.36 | 84.90 | 301 | 5651 | 0.0533 | 0.2326 | MN20160318_Q02 | F05 |
MCF 10A-H2B-mCherry | Dasatinib | 10 | 50.36 | 84.90 | 865 | 5651 | 0.1531 | 0.4672 | MN20160318_Q02 | F05 |
MCF 10A-H2B-mCherry | Dasatinib | 10 | 50.36 | 84.90 | 311 | 5651 | 0.0550 | 0.2391 | MN20160318_Q02 | N03 |
MCF 10A-H2B-mCherry | Dasatinib | 10 | 50.36 | 84.90 | 840 | 5651 | 0.1486 | 0.4600 | MN20160318_Q02 | N03 |
MCF 10A-H2B-mCherry | Dasatinib | 10 | 52.06 | 84.90 | 198 | 5990 | 0.0332 | 0.1485 | MN20160318_Q02 | F05 |
MCF 10A-H2B-mCherry | Dasatinib | 10 | 52.06 | 84.90 | 852 | 5990 | 0.1422 | 0.4558 | MN20160318_Q02 | F05 |
MCF 10A-H2B-mCherry | Dasatinib | 10 | 52.06 | 84.90 | 339 | 5990 | 0.0566 | 0.2529 | MN20160318_Q02 | N03 |
MCF 10A-H2B-mCherry | Dasatinib | 10 | 52.06 | 84.90 | 833 | 5990 | 0.1391 | 0.4504 | MN20160318_Q02 | N03 |
MCF 10A-H2B-mCherry | Dasatinib | 10 | 53.77 | 84.90 | 52 | 6252 | 0.0083 | -0.0760 | MN20160318_Q02 | F05 |
MCF 10A-H2B-mCherry | Dasatinib | 10 | 53.77 | 84.90 | 837 | 6252 | 0.1339 | 0.4463 | MN20160318_Q02 | F05 |
MCF 10A-H2B-mCherry | Dasatinib | 10 | 53.77 | 84.90 | 252 | 6252 | 0.0403 | 0.1917 | MN20160318_Q02 | N03 |
MCF 10A-H2B-mCherry | Dasatinib | 10 | 53.77 | 84.90 | 829 | 6252 | 0.1326 | 0.4440 | MN20160318_Q02 | N03 |
MCF 10A-H2B-mCherry | Dasatinib | 10 | 55.48 | 84.90 | 46 | 6567 | 0.0070 | -0.0931 | MN20160318_Q02 | F05 |
MCF 10A-H2B-mCherry | Dasatinib | 10 | 55.48 | 84.90 | 764 | 6567 | 0.1163 | 0.4194 | MN20160318_Q02 | F05 |
MCF 10A-H2B-mCherry | Dasatinib | 10 | 55.48 | 84.90 | 138 | 6567 | 0.0210 | 0.0805 | MN20160318_Q02 | N03 |
MCF 10A-H2B-mCherry | Dasatinib | 10 | 55.48 | 84.90 | 819 | 6567 | 0.1247 | 0.4352 | MN20160318_Q02 | N03 |
MCF 10A-H2B-mCherry | Dasatinib | 10 | 57.18 | 84.90 | 22 | 6963 | 0.0032 | -0.1914 | MN20160318_Q02 | F05 |
MCF 10A-H2B-mCherry | Dasatinib | 10 | 57.18 | 84.90 | 747 | 6963 | 0.1073 | 0.4078 | MN20160318_Q02 | F05 |
MCF 10A-H2B-mCherry | Dasatinib | 10 | 57.18 | 84.90 | 124 | 6963 | 0.0178 | 0.0614 | MN20160318_Q02 | N03 |
MCF 10A-H2B-mCherry | Dasatinib | 10 | 57.18 | 84.90 | 821 | 6963 | 0.1179 | 0.4289 | MN20160318_Q02 | N03 |
MCF 10A-H2B-mCherry | Dasatinib | 10 | 58.88 | 84.90 | 8 | 7291 | 0.0011 | -0.3077 | MN20160318_Q02 | F05 |
MCF 10A-H2B-mCherry | Dasatinib | 10 | 58.88 | 84.90 | 722 | 7291 | 0.0990 | 0.3954 | MN20160318_Q02 | F05 |
MCF 10A-H2B-mCherry | Dasatinib | 10 | 58.88 | 84.90 | 104 | 7291 | 0.0143 | 0.0321 | MN20160318_Q02 | N03 |